Privia Health Group, Inc. (PRVA) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
↓
57.62
↓-25% vs avg
5yr avg: 77.15
30Y Low58.6·High91.6
P/FCF
↓
18.58
↓-49% vs avg
5yr avg: 36.51
30Y Low18.8·High53.4
P/B Ratio
↓
3.91
↓-16% vs avg
5yr avg: 4.64
30Y Low3.6·High6.2
ROE
↑
3.1%
↓+128% vs avg
5yr avg: -11.1%
30Y Low-63%·High25%
Debt/EBITDA
↓
0.22
↓-14% vs avg
5yr avg: 0.25
30Y Low0.2·High20.8
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PRVA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Privia Health Group, Inc. trades at 133.3x earnings, 7% below its 5-year average of 143.6x, sitting at the 67th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 497%. On a free-cash-flow basis, the stock trades at 18.6x P/FCF, 49% below the 5-year average of 36.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.0B | $3.1B | $2.5B | $2.9B | $2.5B | $2.8B | — | — | — |
| Enterprise Value | $2.5B | $2.6B | $2.0B | $2.5B | $2.2B | $2.5B | — | — | — |
| P/E Ratio → | 133.28 | 131.72 | 177.73 | 121.21 | — | — | — | — | — |
| P/S Ratio | 1.42 | 1.44 | 1.41 | 1.73 | 1.85 | 2.89 | — | — | — |
| P/B Ratio | 3.91 | 3.86 | 3.59 | 4.73 | 4.84 | 6.20 | — | — | — |
| P/FCF | 18.58 | 18.84 | 23.55 | 35.60 | 53.38 | 51.18 | — | — | — |
| P/OCF | 18.44 | 18.70 | 22.47 | 35.55 | 53.26 | 50.67 | — | — | — |
P/E links to full P/E history page with 30-year chart
PRVA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Privia Health Group, Inc.'s enterprise value stands at 57.6x EBITDA, 25% below its 5-year average of 77.1x. The Healthcare sector median is 14.4x, placing the stock at a 301% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.22 | 1.13 | 1.50 | 1.60 | 2.60 | — | — | — |
| EV / EBITDA | 57.62 | 58.58 | 81.25 | 91.62 | — | — | — | — | — |
| EV / EBIT | 74.30 | 75.53 | 116.02 | 120.60 | — | — | — | — | — |
| EV / FCF | — | 15.94 | 18.90 | 30.87 | 46.24 | 46.15 | — | — | — |
PRVA Profitability
Margins and return-on-capital ratios measuring operating efficiency
Privia Health Group, Inc. earns an operating margin of 1.6%. ROE of 3.1% is modest. ROIC of 9.9% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 9.9% | 9.9% | 10.2% | 9.7% | 9.9% | 6.6% | 10.1% | 8.7% | 8.6% |
| Operating Margin | 1.6% | 1.6% | 1.0% | 1.2% | -1.4% | -22.5% | 3.1% | 2.0% | 0.3% |
| Net Profit Margin | 1.1% | 1.1% | 0.8% | 1.4% | -0.6% | -19.5% | 3.8% | 1.0% | -0.5% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.1% | 3.1% | 2.2% | 4.1% | -1.8% | -63.4% | 24.9% | 8.5% | -3.5% |
| ROA | 1.8% | 1.8% | 1.3% | 2.6% | -1.2% | -37.1% | 10.4% | 3.2% | -1.2% |
| ROIC | 9.9% | 9.9% | 6.0% | 7.6% | -8.0% | -121.3% | 19.4% | 11.1% | 1.4% |
| ROCE | 4.6% | 4.6% | 2.6% | 3.6% | -3.7% | -64.1% | 15.1% | 10.6% | 1.5% |
PRVA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Privia Health Group, Inc. carries a Debt/EBITDA ratio of 0.2x, which is very conservative (93% below the sector average of 3.3x). The company holds a net cash position — cash of $480M exceeds total debt of $10M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.10 | 0.23 | 0.40 | 0.78 |
| Debt / EBITDA | 0.22 | 0.22 | 0.23 | 0.30 | — | — | 1.24 | 2.46 | 20.78 |
| Net Debt / Equity | — | -0.59 | -0.71 | -0.63 | -0.65 | -0.61 | -0.35 | -0.04 | 0.32 |
| Net Debt / EBITDA | -10.65 | -10.65 | -20.02 | -14.02 | — | — | -1.87 | -0.22 | 8.65 |
| Debt / FCF | — | -2.90 | -4.66 | -4.73 | -7.15 | -5.03 | -1.32 | -0.20 | 5.55 |
| Interest Coverage | — | — | — | — | — | -203.21 | 13.24 | 2.32 | 0.34 |
Net cash position: cash ($480M) exceeds total debt ($10M)
PRVA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.60x means Privia Health Group, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.81x to 1.60x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.60 | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 | 1.29 | 1.12 | 1.14 |
| Quick Ratio | 1.60 | 1.60 | 1.86 | 1.81 | 2.09 | 2.35 | 1.29 | 1.12 | 1.14 |
| Cash Ratio | 0.84 | 0.84 | 1.09 | 1.01 | 1.32 | 1.68 | 0.58 | 0.41 | 0.39 |
| Asset Turnover | — | 1.55 | 1.53 | 1.66 | 1.71 | 1.41 | 2.48 | 2.91 | 2.64 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 68.93 | 66.46 | 64.02 | 51.01 | 44.35 | 44.28 | 35.90 | 39.50 |
PRVA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Privia Health Group, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 0.8% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.8% | 0.8% | 0.6% | 0.8% | — | — | — | — | — |
| FCF Yield | 5.4% | 5.3% | 4.2% | 2.8% | 1.9% | 2.0% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $129M | $126M | $125M | $111M | $108M | $106M | $106M | $103M |
Peer Comparison
Compare PRVA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PRVAYou | $3B | 133.3 | 57.6 | 18.6 | 9.9% | 1.6% | 3.1% | 9.9% | 0.2 |
 AGIO | $2B | -3.9 | — | — | 78.7% | -873.9% | -30.2% | -26.3% | — |
 CNC | $27B | -4.0 | — | 6.3 | 12.2% | -3.9% | -28.7% | -21.6% | — |
 ALHC | $4B | -4932.4 | 77.1 | 33.0 | 12.4% | 0.4% | -0.5% | — | 7.5 |
 OSCR | $5B | -12.3 | — | 5.1 | 14.4% | -3.4% | -44.4% | — | — |
 DOCS | $5B | 23.5 | 21.1 | 19.6 | 90.2% | 39.9% | 22.5% | 20.0% | 0.1 |
 WELL | $149B | 153.3 | 66.4 | 52.4 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
 UNH | $336B | 27.9 | 16.7 | 20.9 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $111B | 62.8 | 13.1 | 14.3 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 HUM | $30B | 25.1 | 16.9 | 79.1 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 |
 VEEV | $27B | 30.9 | 28.4 | 19.3 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See PRVA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PRVA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PRVA vs AGIO
Side-by-side business, growth, and profitability comparison vs Agios Pharmaceuticals, Inc..
Start ComparisonPRVA — Frequently Asked Questions
Quick answers to the most common questions about buying PRVA stock.
What is Privia Health Group, Inc.'s P/E ratio?
Privia Health Group, Inc.'s current P/E ratio is 133.3x. The historical average is 143.6x. This places it at the 67th percentile of its historical range.
What is Privia Health Group, Inc.'s EV/EBITDA?
Privia Health Group, Inc.'s current EV/EBITDA is 57.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 77.1x.
What is Privia Health Group, Inc.'s ROE?
Privia Health Group, Inc.'s return on equity (ROE) is 3.1%. The historical average is -3.2%.
Is PRVA stock overvalued?
Based on historical data, Privia Health Group, Inc. is trading at a P/E of 133.3x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Privia Health Group, Inc.'s profit margins?
Privia Health Group, Inc. has 9.9% gross margin and 1.6% operating margin.
How much debt does Privia Health Group, Inc. have?
Privia Health Group, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.